A next-generation oral solid CDMO delivering integrated formulation and manufacturing from clinic to commercial.
Commercial-scale manufacturing capacity across oral solid dosage forms, supporting reliable supply and regulatory compliance from launch onward.
Deep expertise in solubility enhancement, amorphous solid dispersion, and modified-release technologies to reduce risk and accelerate development.
Integrated formulation, scale-up, and commercial production capabilities in one campus, enabling seamless progression from clinical programs to market supply.
